There are 2789 resources available
1464P - Clinical factors associated with survival time from the last administration of systemic anticancer therapy to death in patients with advanced cancer
Presenter: Shuji Hiramoto
Session: ePoster Display
1315P - Impact of high fasting plasma glucose in the clinical outcome of patients with advanced NSCLC with PD-L1 ≥ 50% treated with frontline pembrolizumab
Presenter: Sandra Llop Serna
Session: ePoster Display
1317P - Renal toxicity in black patients with non-squamous non-small cell lung cancer treated with combination platinum-pemetrexed-pembrolizumab therapy
Presenter: Nino Balanchivadze
Session: ePoster Display
1319P - Impact of bone radiotherapy on immune checkpoint inhibitors efficacy in patients with metastatic non-small cell lung cancer: A single-institution experience
Presenter: guido natoli
Session: ePoster Display
1468P - POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
Presenter: Talia Golan
Session: ePoster Display
1470P - Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence
Presenter: Thatcher Heumann
Session: ePoster Display
1324P - Clinical and laboratory features: How they influence immunotherapy response in non-small cell lung cancer
Presenter: Ricardo Gomes
Session: ePoster Display